The Disease X has been identified as an unknown pathogen that has the potential to cause a serious international epidemic, according to the World Health Organization.
Covaxin makers Bharat Biotech also in a statement said that the targeted narrative against Covaxin is misleading and asserted that there was no external pressure to accelerate the development of Covaxin. The company clarified that the pressure was all internal to develop a safe, and effective vaccine for the Covid-19 pandemic.
In an interim report, titled ‘An Analysis of the Origins of the COVID-19 Pandemic,’ the US Senate Republicans investigated the origin of the COVID virus and explained how it could have started from a laboratory leak.
"Since December 2021, we stopped the production (of Covishield). We had a stock of a few hundred million doses at that time and of that, 100 million doses have already expired," said Poonawalla when asked about the update on the Covishield vaccine.
Lukin said she expects the vaccine - currently provided for free to all by the government - will be made available at no cost to people who have private insurance or government paid insurance.
The WHO's emergency committee first made the declaration for COVID-19 on Jan 30, 2020. Such a determination can help accelerate research, funding and international public health measures to contain a disease.
According to the Maharashtra Health Department, the XXB variant of covid-19 will reach its peak in mid-November, after the festivities are over. Maharashtra has recorded 18 cases of XBB sub-variant of Omicron detected in 15 days.
India on Tuesday recorded a single-day rise of 1,542 coronavirus infections, which is its lowest in last six months. The active cases comprise 0.06 per cent of the total infections, while the national Covid-19 recovery rate has increased to 98.76 per cent
The Long-CISS (COVID In Scotland Study) -- found that 1 in 20 people who took part in the research had not recovered from having COVID-19 at their most recent follow up -- between six and 18 months following infection with SARS-CoV-2.
Despite the continuous circulating of new variants and sub-variants, the COVID vaccine continues to provide high protection against severe disease and death. The strains of flu also change each winter and are, to some extent, unpredictable.
India’s active caseload currently stands at 36,126. Active cases now constitute 0.08 per cent of the country's total Positive Cases, according to union health ministry data. At least 3,011 new cases were reported in the last 24 hours.
“Administration of Precaution Dose is pivotal to confer full/extended protection to beneficiaries against Covid-19. It helps to reduce the severity of the COVID-19 disease, risk of hospitalization and thereby reduces mortality,” said the government.
The pandemic will be over but Covid will be here to stay, the scientists said as Covid numbers begin to ebb in several parts of the world, including India.
The commission said that lack of cooperation among governments for the financing and distribution of key health commodities—including vaccines, personal protective equipment, and resources for vaccine development and production in low-income countries—has come at dire costs.
